|
1
|
Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.
|
Clin Cancer Res
|
2001
|
1.35
|
|
2
|
1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo.
|
Cancer Res
|
1999
|
1.27
|
|
3
|
Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone.
|
J Natl Cancer Inst
|
1998
|
0.97
|
|
4
|
A novel approach for the identification of unique tumor vasculature binding peptides using an E. coli peptide display library.
|
Ann Surg Oncol
|
2000
|
0.95
|
|
5
|
Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells.
|
Cancer Res
|
1996
|
0.85
|
|
6
|
Vitamin D: an antiproliferative agent with potential for therapy of squamous cell carcinoma.
|
Am J Otolaryngol
|
1997
|
0.82
|
|
7
|
Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
|
Cancer Res
|
1994
|
0.77
|
|
8
|
Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice.
|
Cancer Chemother Pharmacol
|
1993
|
0.77
|
|
9
|
Sister chromatid exchange induced by etheno-ATP derivatives in vitro.
|
Cancer Res
|
1989
|
0.75
|
|
10
|
Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells.
|
Cancer Res
|
1996
|
0.75
|
|
11
|
Gene therapy and endothelial cell targeting for cancer.
|
Ann N Y Acad Sci
|
1994
|
0.75
|